The debate about useful markers to predict prostate cancer is still open. According to Dr. Juan Morote, Head of Urology Service at Vall d’Hebron Hospital, and responsible of the study published in the last edition of the "http://www.bjuinternational.com/" British Journal of Urology International, "Several inconclusive studies have been published indicating that patients with a testosterone deficiency had more possibilities to have prostate cancer". "http://urologia.diariomedico.com/2010/01/05/area-cientifica/especialidades/urologia/un-estudio-del-valle-de-hebron-confirma-que-la-relacion-entre-testosterona-y-psa-no-predice-cancer-de-prostata"